Patent Foramen Ovale Closure or Anticoagulation vs. Antiplatelets after Stroke

Mas, Jean‐Louis; Dérumeaux, Geneviève; Guillon, B.; Massardier, Evelyne; Hosseini, Hassan; Mechtouff, Laura; Arquizan, Caroline; Béjot, Yannick; Vuillier, Fabrice; Detante, Olivier; Guidoux, Céline; Canaple, Sandrine; Vaduva, Claudia; Dequatre‐Ponchelle, Nelly; Sibon, Igor; Garnier, Pierre; Ferrier, Anna; Timsit, Serge; Robinet-Borgomano, Emmanuelle; Sablot, Denis; Lacour, Jean‐Christophe; Zuber, Mathieu; Favrole, Pascal; Pinel, Jean‐François; Apoil, Marion; Reiner, Peggy; Lefebvre, Catherine; Guérin, Patrice; Piot, Christophe; Rossi, Roland; Dubois‐Randé, Jean‐Luc; Eicher, Jean‐Christophe; Meneveau, Nicolas; Lusson, Jean‐René; Bertrand, Bernard; Schleich, Jean‐Marc; Godart, François; Thambo, Jean‐Benoît; Leborgne, Laurent; Michel, Patrik; Piérard, Luc; Turc, Guillaume; Barthelet, Martine; Charles‐Nelson, Anaïs; Weimar, Christian; Moulin, Thierry; Juliard, Jean‐Michel; Châtellier, Gilles

doi:10.1056/nejmoa1705915

Public

Patent Foramen Ovale Closure or Anticoagulation vs. Antiplatelets after Stroke

Published in New England Journal of Medicine • Sep 13, 2017

Authors:

Jean‐Louis Mas

Geneviève Dérumeaux

B. Guillon

Abstract

BACKGROUND: Trials of patent foramen ovale (PFO) closure to prevent recurrent stroke have been inconclusive. We investigated whether patients with cryptogenic stroke and echocardiographic features representing risk of stroke would benefit from PFO closure or anticoagulation, as compared with antipla...

Subject

Medicine

Patent foramen ovale

Stroke (engine)

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!